Research on individuals from Itabaianinha County, Brazil, who have severe congenital IGHD due to a homozygous GHRHR gene mutation and have never received treatment shows significant physical consequences such as severe short stature (ranging from 105 to 135 cm), central obesity, dyslipidemia, and elevated systolic blood pressure. This evidence concerns the gene GHRHR and metabolic syndrome.